57692-03-2

2H-Pyran, 2-[(5-bromo-2-pentenyl)oxy]tetrahydro-, (Z)-

3-Hexenoic acid,6-[4-[cyclohexyl[(2-thiazolylamino)carbonyl]amino]-1-piperidinyl]-6-oxo-,(3E)-

Cyclobutanecarboxylic acid,1-[[[2-[[[cyclohexyl(trans-4-methylcyclohexyl)amino]carbonyl]amino]-5-thiazolyl]sulfonyl]amino]-

Urea,N-(1-acetyl-4-piperidinyl)-N-(trans-4-methylcyclohexyl)-N'-[5-[[2-oxo-2-[4-(2-pyrimidinyl)-1-piperazinyl]ethyl]thio]-2-thiazolyl]-

Cycloheptanamine, N-(trans-4-phenylcyclohexyl)-

5-Thiazolecarboxamide,2-[[(dicyclohexylamino)carbonyl]amino]-N-(2-hydroxyethyl)-4-methyl-

N-[(3R,4S)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl]-N-hydroxyacetamide

2,5-DICYANOBENZOTRIFLUORIDE

PTA1 protein

Propanoic acid,3-[[2-[[[cyclohexyl(trans-4-ethoxycyclohexyl)amino]carbonyl]amino]-5-thiazolyl]thio]-

2(1H)-Aceanthrylenone, 1,1-dimethyl-

1-Naphthalenesulfonamide,4-chloro-N-(2,3,4,5-tetrahydro-1H-2-benzazepin-8-yl)-

5-Thiazolesulfonamide,2-[[[cyclohexyl(trans-4-methylcyclohexyl)amino]carbonyl]amino]-N-methyl-

DOCETAXEL SIDE CHAIN NO 1

yemanuclein-alpha protein

Cycloheptanamine, N-[trans-4-(1,1-dimethylethyl)cyclohexyl]-

1H-1,2,3-Triazole,4-[2-[(1,1-dimethylethyl)dimethylsilyl]ethynyl]-1-(phenylmethyl)-

Tetradecanamide,N-[1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxypentadecyl]-,[R-(R*,R*)]-

b-Alanine,N-[[2-[[[cyclohexyl(trans-4-methylcyclohexyl)amino]carbonyl]amino]-5-thiazolyl]sulfonyl]-

Propanoic acid,3-[[2-[[[cycloheptyl(trans-4-methoxycyclohexyl)amino]carbonyl]amino]-5-thiazolyl]thio]-

Cycloheptanamine,N-[trans-4-[[4-(trifluoromethyl)phenoxy]methyl]cyclohexyl]-

adipose differentiation-related protein

1-Tetradecanol, 3-(phenylmethoxy)-, (R)-

Cyclohexanamine, N-cyclohexyl-4-[(2-methyl-2-propen-1-yl)oxy]-, trans-

1,6-Naphthalenediol, [(hydroxymethylphenylene)bis(methylene)]bis-

Acetic acid,2-[[2-[[[cyclohexyl[trans-4-[(cyclopropylmethoxy)methyl]cyclohexyl]amino]carbonyl]amino]-5-thiazolyl]thio]-

Urea,N-cyclohexyl-N-(trans-4-methylcyclohexyl)-N'-[5-(1-piperidinylsulfonyl)-1,3,4-thiadiazol-2-yl]-

D-Proline,1-[[2-[[[cyclohexyl(trans-4-methylcyclohexyl)amino]carbonyl]amino]-5-thiazolyl]sulfonyl]-

1-Naphthalenesulfonamide,4-chloro-N-[4-(2-fluoroethyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl]-

Benzenesulfonamide,N-(2,3,4,5-tetrahydro-1H-2-benzazepin-8-yl)-2-(trifluoromethyl)-

1,4-Benzoxazepine, 9-chloro-2,3,4,5-tetrahydro-4-(1-methylethyl)-

1-Tetradecanamine, 2-dodecyl-N,N-dimethyl-

CitrusinIV

p40 protein, human

3,5-Pyridinedicarbonitrile,2-amino-4-(4-chlorophenyl)-6-[[2-(diethylamino)ethyl]thio]-

5-Thiazolesulfonamide,2-[[[cyclohexyl(trans-4-methylcyclohexyl)amino]carbonyl]amino]-N-(1,1-dimethylethyl)-

(~133~I)hydrogen iodide

57692-03-2 msds

CAS No 57692-03-2 supplier

CASNo 57692-03-2 distributor

CAS # 57692-03-2 manufacturer

CAS Number 57692-03-2 safety

CAS RN 57692-03-2 wholesale

2026-10-12 Find 2H-Pyran, 2-[(5-bromo-2-pentenyl)oxy]tetrahydro-, (Z)-,CAS No.57692-03-2,Formula:C10H17BrO2 in ChemTaobao